Zika virus and other emerging & reemerging infectious diseases
Ended Awarded Last action
- Contract number
- HHSN26100020
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,010,202
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $2,010,201.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $6,399 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $3,846 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,999,957 |
About this award
This federal contract award, with an ID of HHSN261201500003I|HHSN26100020, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The $2,010,201.84 contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., on September 1, 2016, with a performance period ending on September 30, 2019. The contract is a Delivery Order, with a Cost No Fee pricing type. It does not have a set-aside designation.
Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute, providing a range of biomedical research and facilities support services to federal agencies, with a focus on the National Institutes of Health. The company has supported research efforts across various disease areas, including COVID-19, and has participated in federal grant-funded research projects through sub-awards.
Quick answers
Who was awarded contract HHSN26100020?
HHSN26100020 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2016.
How much is contract HHSN26100020 worth?
The government has obligated $2,010,202 on HHSN26100020.
Which agency awarded contract HHSN26100020?
National Cancer Institute (National Institutes of Health) awarded HHSN26100020, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract HHSN26100020 an order under another contract?
Yes. HHSN26100020 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100020 competed?
The extent of competition for HHSN26100020 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award